ZA91372B - Oral pharmaceutical forms a pimobendan - Google Patents

Oral pharmaceutical forms a pimobendan

Info

Publication number
ZA91372B
ZA91372B ZA91372A ZA91372A ZA91372B ZA 91372 B ZA91372 B ZA 91372B ZA 91372 A ZA91372 A ZA 91372A ZA 91372 A ZA91372 A ZA 91372A ZA 91372 B ZA91372 B ZA 91372B
Authority
ZA
South Africa
Prior art keywords
pimobendan
oral pharmaceutical
pharmaceutical forms
variations
citric acid
Prior art date
Application number
ZA91372A
Other languages
English (en)
Inventor
Peter Gruber
Gruber Peter
Willy Roth
Roth Willy
Gottfried Schepky
Schepky Gottfried
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ZA91372B publication Critical patent/ZA91372B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA91372A 1990-01-20 1991-01-18 Oral pharmaceutical forms a pimobendan ZA91372B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4001622A DE4001622A1 (de) 1990-01-20 1990-01-20 Orale arzneimittelformen von pimobendan

Publications (1)

Publication Number Publication Date
ZA91372B true ZA91372B (en) 1992-09-30

Family

ID=6398467

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA91372A ZA91372B (en) 1990-01-20 1991-01-18 Oral pharmaceutical forms a pimobendan

Country Status (18)

Country Link
EP (1) EP0439030B1 (ko)
JP (1) JP2608183B2 (ko)
KR (1) KR0163056B1 (ko)
AT (1) ATE87481T1 (ko)
AU (1) AU630536B2 (ko)
CA (1) CA2034569C (ko)
DE (2) DE4001622A1 (ko)
DK (1) DK0439030T3 (ko)
ES (1) ES2054379T3 (ko)
FI (1) FI96274C (ko)
HK (1) HK175796A (ko)
HU (1) HU207948B (ko)
IE (1) IE64659B1 (ko)
IL (1) IL96995A (ko)
NO (1) NO176305C (ko)
NZ (1) NZ236834A (ko)
PT (1) PT96506B (ko)
ZA (1) ZA91372B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
JP3996626B2 (ja) * 2004-06-22 2007-10-24 塩野義製薬株式会社 口腔内速崩壊錠
JP4572293B2 (ja) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
JP4572296B2 (ja) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
JP2006028130A (ja) * 2004-07-21 2006-02-02 Toa Eiyo Ltd ピモベンダン経口投与製剤
US20070105867A1 (en) * 2005-09-21 2007-05-10 Bristol-Myers Squibb Company Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
JP4572300B2 (ja) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
PE20081482A1 (es) * 2006-12-20 2008-12-23 Novartis Ag Capsulas de gelatina que contienen un acido
FR2934156B1 (fr) * 2008-07-23 2010-09-24 Virbac Medicament appetissant a administration orale sous forme solide
WO2010055119A2 (en) * 2008-11-17 2010-05-20 Novartis Ag Pharmaceutical composition comprising pimobendan
ES2436716T3 (es) 2008-11-25 2014-01-03 Boehringer Ingelheim Vetmedica Gmbh Pimobendan para uso en el tratamiento de la cardiomiopatía hipertrófica en gatos
NL1037569C2 (en) 2009-12-18 2011-06-21 Eurovet Animal Health B V Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN106729723A (zh) * 2016-11-21 2017-05-31 青岛农业大学 一种含匹莫苯丹的药物组合物及其制备方法
US20240197727A1 (en) 2022-12-15 2024-06-20 Boehringer Ingelheim Vetmedica Gmbh Solid dispersions comprising amorphous pimobendan and one or more stabilizing polymers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2837161A1 (de) * 1978-08-25 1980-03-06 Thomae Gmbh Dr K Neue benzimidazole und deren verwendung
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
EP0266707B1 (en) * 1986-11-03 1992-01-22 Schering Corporation Sustained release labetalol tablet
DE3728244A1 (de) * 1987-08-25 1989-03-09 Thomae Gmbh Dr K Neue (-)-benzimidazole, deren herstellung und diese verbindungen enthaltende arzneimittel
EP0306846A3 (de) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
DE3805635A1 (de) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
JPH01258621A (ja) * 1988-04-06 1989-10-16 Fujimoto Seiyaku Kk 吸収が調節されたジラゼプ錠
JPH023609A (ja) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk 塩酸ニカルジピンを活性成分とする持効性製剤

Also Published As

Publication number Publication date
AU630536B2 (en) 1992-10-29
FI910263A (fi) 1991-07-21
HU910177D0 (en) 1991-08-28
EP0439030A2 (de) 1991-07-31
FI910263A0 (fi) 1991-01-18
CA2034569A1 (en) 1991-07-21
KR910014120A (ko) 1991-08-31
IE64659B1 (en) 1995-08-23
HU207948B (en) 1993-07-28
EP0439030B1 (de) 1993-03-31
JPH04210919A (ja) 1992-08-03
ATE87481T1 (de) 1993-04-15
ES2054379T3 (es) 1994-08-01
PT96506A (pt) 1991-10-15
CA2034569C (en) 2002-03-19
IL96995A0 (en) 1992-03-29
NZ236834A (en) 1995-10-26
AU6945491A (en) 1991-07-25
NO176305B (no) 1994-12-05
HUT56494A (en) 1991-09-30
IE910165A1 (en) 1991-07-31
DE59100067D1 (de) 1993-05-06
NO910213D0 (no) 1991-01-18
KR0163056B1 (ko) 1998-12-01
DE4001622A1 (de) 1991-07-25
NO176305C (no) 1995-03-15
IL96995A (en) 1994-11-11
EP0439030A3 (en) 1991-10-16
HK175796A (en) 1996-09-27
DK0439030T3 (da) 1993-08-16
PT96506B (pt) 1998-06-30
FI96274C (fi) 1996-06-10
FI96274B (fi) 1996-02-29
JP2608183B2 (ja) 1997-05-07
NO910213L (no) 1991-07-22

Similar Documents

Publication Publication Date Title
ZA91372B (en) Oral pharmaceutical forms a pimobendan
IT8822379A0 (it) Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon.
NO912607D0 (no) Oral, fast farmasoeytisk doseringsform med programmert frigivelse.
ITBO910024A1 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
DZ1876A1 (fr) Médicaments pour administration orale.
GR3036937T3 (en) Pharmaceutical formulations.
ZA917528B (en) Nasal pharmaceutical composition.
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
ZA929330B (en) Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives.
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
CY1975A (en) Pharmaceutical formulation containing dirithromycin
ITRM920535A0 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
IT8583453A0 (it) Gruppo di trasferimento del pietrisco per profilatrice trasferitrice per massicciata e profilatrice cosi' equipaggiata.
ATE165239T1 (de) Orale arzeimittelzubereitung enthaltend diclofenac-natrium und eine organische säure
ZA928275B (en) Quinoxaline-carboxylic and -phosphonic acid derivatives.
EP0575583A4 (en) BICYCLOPOLYAZAMACROCYCLOCARBOXYLIC ACID COMPLEXES, THEIR CONJUGATES, THEIR PREPARATION METHODS AND THEIR USES AS RADIOPHARMACEUTICAL AGENTS.
NO903130D0 (no) Fremgangsmaate for aa oeke trykket i en broennstroem.
IS4288A (is) 2,4-dísúlfónýlfenýlbútýlnítrón, sölt þess, lyfjablanda ásamt notkun á þessu efnasambandi við framleiðslu á lyfi
ZA928736B (en) Amino acid derivatives.
MW491A1 (en) Osmotic,oral dosage form for fertility control
IT9021846A1 (it) Involucro pretettivo, particolarmente studiato per l'impiego in ambito ospedaliero.
ZW3291A1 (en) Osmotic,oral dosage form for fertility control
ZM1191A1 (en) Osmotic,oral dosage form for fertility control
IE901219L (en) Amino acid derivatives.
IE901205L (en) Amino acid derivatives.